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Small GTPases of the Rho family have been implicated in the regulation of many intracellular processes. However, their tissue-specific roles in
mammalian growth and development in vivo remain largely unknown. Here we describe the effects of cartilage-specific inactivation of the Rac1
gene in mice. Mice carrying this mutation show increased lethality, skeletal deformities, severe kyphosis and dwarfism. Rac1-deficient growth
plates are disorganized and hypocellular, with chondrocytes of abnormal shape and size. Rac1-deficient chondrocytes also display reduced
adhesion and spreading on collagen II and fibronectin as well as altered organization of the actin cytoskeleton, suggesting that Rac1 is required for
normal cell–extracellular matrix interactions in cartilage. This phenotype is accompanied by reduced proliferation, increased apoptosis and
deregulated expression of the cell cycle genes cyclin D1 and p57 in vivo. Moreover, phosphorylation of p38 MAP kinases is greatly reduced and
expression of a key regulator of cartilage development, Indian hedgehog, is increased in mutant mice. In summary, these data identify a novel,
essential and tissue-specific role of Rac1 in skeletal development and demonstrate that Rac1 deficiency affects numerous regulatory pathways in
cartilage.
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The majority of the mammalian skeleton is formed through
the process of endochondral ossification in which the later
bones are first laid down as cartilage anlagen (Karsenty and
Wagner, 2002; Olsen et al., 2000; Stanton et al., 2003).
Chondrocytes within these anlagen undergo a strictly controlled
program of proliferation, differentiation and apoptosis that is
spatially contained within the growth plate, resulting in the
replacement of cartilage by bone (Ballock and O'Keefe, 2003;
Kronenberg, 2003; van der Eerden et al., 2003). Proliferation of
chondrocytes along the longitudinal axis of the bone results in
the establishment of characteristic columns of flattened
chondrocytes that subsequently exit the cell cycle and initiate
terminal differentiation. Both progression through the cell cycle⁎ Corresponding author. Fax: +1 519 661 3827.
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such as parathyroid hormone-related protein and members of
the fibroblast growth factor, transforming growth factor β and
hedgehog families (Ballock and O'Keefe, 2003; Kronenberg,
2003; van der Eerden et al., 2003). Differentiation is
accompanied by a drastic increase in cell size giving rise to
hypertrophic chondrocytes that ultimately undergo apoptosis.
Hypertrophic cartilage is invaded by blood vessels that
introduce osteoblasts precursor cells and osteoclasts, leading
to remodeling of the cartilage extracellular matrix (ECM) and to
adhesion of bone-producing cells to the remnants of this ECM.
These processes result in the replacement of cartilage by bone
and bone marrow.
Coordinated proliferation and hypertrophy of growth plate
chondrocytes drive longitudinal growth of endochondral bones
and therefore determine body length in mammals. Interplay of
the multitude of extracellular factors acting on chondrocytes
results in very tight regulation of these processes, and disturbances
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generally cause dwarfism and skeletal deformities (Ballock and
O'Keefe, 2003; van der Eerden et al., 2003; Zelzer and Olsen,
2003). Recent studies have provided strong evidence for
important roles of signaling from the extracellular matrix
(ECM) in the regulation of chondrocyte behaviour. For example,
mice with cartilage-specific inactivation of the β1 integrin or
integrin-linked kinase (ILK) genes (Aszodi et al., 2003; Grashoff
et al., 2003; Terpstra et al., 2003) or ubiquitous inactivation ofα10
integrin (Bengtsson et al., 2005) or DDR2 (Labrador et al., 2001)
genes show dwarfism and growth plate defects. One common
feature of all these mouse models is reduced chondrocyte
proliferation.
The Rho GTPases constitute a family of signaling proteins
involved in signaling from adhesive receptors, including
integrins (Arthur et al., 2002; DeMali et al., 2003; Juliano,
2002; Juliano et al., 2004). These proteins act as molecular
switches; when bound to GDP, they are inactive, but upon
exchange of GDP for GTP, they bind to and activate a number of
downstream effectors that regulate multiple cellular processes
such as actin dynamics, gene expression and cell cycle
progression (Symons and Settleman, 2000; Takai et al., 2001).
Our in vitro studies suggested important roles of the prototype
family members RhoA, Rac1 and Cdc42 in the control of
chondrocyte proliferation, hypertrophy and apoptosis (Wang
and Beier, 2005; Wang et al., 2004; Woods and Beier, 2006;
Woods et al., 2005). In particular, we have shown that Rac1
accelerates progression through the chondrogenic program in a
pathway that is partially dependent on p38 MAP kinase activity
(Wang and Beier, 2005), in agreement with other studies
showing a role for p38 signaling in chondrocytes (Stanton et al.,
2003, 2004; Zhang et al., 2006; Zhen et al., 2000). However, the
in vivo roles of Rho GTPases in chondrocytes or other skeletal
lineages are unknown.
In this study, we examined the role of Rac1 in cartilage
development in vivo. Because Rac1-deficient mice die early in
development (Sugihara et al., 1998), we inactivated the gene
specifically in chondrocytes using the Cre loxP system. Loss of
Rac1 in cartilage results in a number of phenotypes including
reduced viability, dwarfism, kyphosis and disorganization of the
growth plate, with concurrent changes in several pathways
known to regulate endochondral ossification. Overall, these
studies demonstrate a strong requirement for Rac1 in cartilage
development and identify several downstream mechanisms
mediating Rac1 effects in chondrocytes.Materials and methods
Materials
The following antibodies were employed in this study: Rac1 #BK035
(Cytoskeleton); Cre #C7988, Collagen X #C7974, Vinculin #V4139 (Sigma-
Aldrich); Phospho-Akt (Ser473) #9271, Akt #9273, Phospho-p38 #9216, p38
#9212 (Cell Signaling Technology); PECAM-1 #1506, Kip2/p57 #sc8298,
patched #sc6149, Goat-anti-rabbit #sc2004, Goat-anti-mouse #sc2005, Rabbit-
anti-goat #sc2768 (Santa Cruz Biotechnology); Y397 Phospho-FAK #44-624G,
FITC-conjugated-anti-rabbit #ALI3408 (BIOSOURCE). Type II collagen
(#C7510-21) was purchased from US Biological and Fibronectin (#33010-018) was from Invitrogen. General chemicals and supplies were purchased from
Sigma and VWR, cell culture reagents from Invitrogen.
Mouse breeding and genotyping
Mice were exposed to a 12-h light–dark cycle and fed tap water and regular
chow ad libitum. All procedures involving animals were approved by the
University of Western Ontario Animal Care and Use Committee. PCR
genotyping was performed from tail snip DNA by simultaneous amplification
of the wild-type (Rac1+), conditional (Rac1fl/fl), and null (Rac1-) alleles
(Glogauer et al., 2003) and for the Cre transgene (Terpstra et al., 2003) as
described.
Immunoprecipitation and western blotting
Fresh cartilage from limbs of newborn mice was dissected in cold Puck's
solution A (PSA) (Stanton et al., 2004). RIPA extracts of cartilage were used
directly for western blotting (Rac1) or for immunoprecipitation (p38, Akt). For
immunoprecipitation, RIPA extracts were incubated overnight with antibodies
followed by addition of protein A-Sepharose (Pharmacia) for 2 h. Beads were
centrifuged for 4 min at 4000 rpm and washed three times with 1% Triton X-
100, 0.5 M NaCl and 10 mM Tris–HCl, pH 7.4. SDS-PAGE sample buffer
(100 μl) was added to immunoprecipitates, and samples were boiled for 5 min,
separated by SDS-polyacrylamide gel electrophoresis and transferred to
polyvinylidene difluoride membranes (Amersham). Blocking, incubation with
antibodies and washing were carried out in accordance with instructions of the
supplier of the primary antibody. Immunoblots were developed using the ECL
detection system (Amersham). Representative blots from three independent
experiments are shown.
Histology and immunohistochemistry
Freshly dissected bones were fixed with 10% buffered formalin and
decalcified with 0.1 M EDTA at room temperature before embedding and
sectioning at the Robarts Research Institute Molecular Pathology Core Facility
(London, ON). 5- to 8-μm sections were dewaxed in xylene followed by a
graded series of alcohol washes. Sections were stained with hematoxylin/eosin
or safranin O/Fast green. Sections were incubated in 3% H2O2 for 15 min at
room temperature, followed by boiling for 20 min in 10 mM sodium citrate (pH
6.0) and blocking with 5% goat serum. Sections were incubated with primary
antibodies over night at 4 °C and secondary antibodies according to the
manufacturers' recommendations. After washing, the sections were incubated
for 2–10 min with DAB substrate solution, washed and mounted. All images
were taken at room temperature with a Retiga EX camera connected to a Leica
DMRA2 fluorescence microscope. Primary image analyses were performed
using OpenLab 4.0.4 software. For cell counts in sections, all cells or cells
labelled with anti-BrdU or anti-cyclin D1 antibodies were counted from three
different areas of one section. Sections from three different mice per genotype
were analyzed, and averages and standard error of the mean (SEM) from all nine
counts/genotype are shown.
Skeletal staining
Animals were skinned, eviscerated and dehydrated in 95% ethanol overnight
and then in acetone overnight. Skeletons were stained with 0.015% alcian blue,
0.05% alizarin red and 5% acetic acid in 70% ethanol for several days. Skeletons
were then cleared in 1% KOH, passed through a decreasing KOH series and
stored in glycerol/ethanol (1:1).
BrdU labelling and TUNEL analyses
For BrdU labelling, newborn mice were injected 1 h before sacrifice
intraperitoneally with BrdU (Roche) at a dose of 0.01 ml/g. BrdU was detected
in paraffin sections using an anti-BrdU antibody (Zymed Laboratories) as above.
TUNEL assays were performed using the DeadEndTM Fluorometric TUNEL
System (Promega) according to the manufacturer's instructions.
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Total RNA was isolated from epiphysis cartilage of long bone from newborn
mice using TRIzol (Invitrogen), according to the manufacturer's recommendations.
Taqman real-time PCR was performed as described (James et al., 2005; Stanton et
al., 2004; Woods et al., 2005) with primers and probe sets from Applied
Biosystems; data were normalized to Gapdh mRNA levels and represent averages
and SEM from direct comparison of mutant and control littermates from three
crosses. Statistical significance of real-time PCR results was determined by two-
way ANOVAwith Bonferroni post-test using GraphPad Prism 3.00 for Windows.
Primary cultures of chondrocytes and adhesion assays
Primary chondrocytes were prepared from long bones of newborn mice. Briefly,
the cartilage was dissected from long bones, rinsed in PBS and incubated at 37 °C for
15 min in trypsin-EDTA followed by digestin with 2 mg/ml collagenase P at 37 °C
for 2 h in Dulbecco's Modified Eagles Medium (DMEM). The cell suspension
filtered through a 70-μm cell strainer (Falcon), washed, counted and plated. For cell
adhesion assays, 1×105/ml chondrocytes were seeded for 30 min at 37 °C in DMEM
supplemented with 2% bovine serum albumin on glass Lab-Tek chamber slides in 24-
well plates (Nunc) coated with 10 μg/ml fibronectin or 100 μg/ml type II collagen.
Background adhesion was measured using BSA-coated plates. After washing,
adhered cells were trypsinized and counted. All data represent averages and SEM
from three independent cell isolations. For F-actin staining, cells were allowed to
adhere for 24 h and stained with Rhodamine Phalloidin and DAPI. For vinculin and
phospho-focal adhesion kinase (FAK) immunofluorescence, fixed cells on coverslips
were blocked with 5% goat serum for 30 min at room temperature and incubated with
anti-vinculin or anti-phospho-FAK (Y397) antibodies followed by FITC-conjugated
anti-rabbit secondary antibody. Images were acquired as described above.Results
Cartilage-specific inactivation of Rac1 results in reduced
viability and growth
We used a genetic approach to address the role of Rac1
signaling in cartilage development in vivo. Since Rac1 null mice
are embryonic lethal (Sugihara et al., 1998), we employed the
Cre-LoxP system for cartilage-specific inactivation of the gene.
Mice with a conditional (‘floxed’) mutation in both alleles of the
Rac1 gene (Rac1fl/fl) (Glogauer et al., 2003) were crossed to
mice expressing Cre recombinase under the control of the mouse
collagen II (Col2a1) promoter (Terpstra et al., 2003) to yield
Rac1fl/+/Col2Cre mice. In order to obtain Rac1fl/fl/Col2Cre
mice, we then crossed Rac1fl/+/Col2Cre and Rac1fl/fl mice.
Western blot analyses demonstrated that Rac1fl/fl/Col2Cre
mice displayed greatly reduced levels of Rac1 protein in
cartilage when compared to control mice (Rac1fl/fl without Cre
or Rac1fl/+/Cre mice), whereas no genotype-dependent differ-
ences in Rac1 levels were observed in brain, lung and kidney
extracts (Fig. 1A). Analyses of histological sections by
immunohistochemistry showed that Rac1 protein is expressed
in all zones of the growth plate in control mice, but demonstrated
almost complete loss of Rac1 immunoreactivity in the proli-
ferative and hypertrophic zones of Rac1fl/fl/Cre mice (Fig. 1B).
Interestingly, weak Rac1 signal is still maintained in some
resting chondrocytes of mutant mice, indicating incomplete
recombination that might be due to lower activity of the collagen
II promoter and/or earlier differentiation stage of these cells.
These data demonstrate efficient and specific reduction of Rac1
expression in Rac1fl/fl/Cre mice.Based on our breeding protocol, Mendelian ratio would
predict that 25% of newborn mice from our crosses have the
Rac1fl/fl/Cre genotype (referred to as Rac1 KD genotype
hereafter). However, examination of genotype distribution
during the first 2 weeks after birth revealed that only 13% of
pups carry the KD genotype (Fig. 1C), while 9 out of 10
stillborn mice collected during this study were KDs (data not
shown). Analyses of genotypes at different embryonic stages
showed the expected Mendelian distribution (data not shown).
These data indicate that loss of Rac1 expression in cartilage
results in reduced viability, with death occurring during or
shortly after birth. Observation of newborn litters suggested that
mutant mice suffer from respiratory distress, providing a
potential explanation for their increased lethality. Analyses of
litters demonstrated significant growth retardation in surviving
Rac1 KD mice (Fig. 1D). Detailed analyses of growth over
the first 6 weeks of life revealed that KD mice were shorter and
weighed less at birth, and differences in both parameters
increased as the animals aged (Figs. 1E, F). Growth retardation
was similar in male and female mice (data not shown).
Rac1 deficiency causes kyphosis and delayed ossification
We next examined the skeletal phenotype of Rac1-deficient
mice. Whole-mount skeletal staining with alcian blue and
alizarin red confirmed that newborn mutant mice have a smaller
skeleton than control littermates (Fig. 2A). The vast majority of
mutant mice displayed severe kyphosis from birth onwards,
although no obvious morphological changes in the axial
skeleton could be found (with the exception of increased
curvature; Fig. 2B). Detailed observation of selected vertebra
showed no obvious differences besides the reduced size in
mutants. Measurements of individual bones revealed that tibias
and femurs were significantly shorter in newborn KD mice (Fig.
2C). Staining of skeletal elements at postnatal day 21 confirmed
severe growth retardation in mutant mice, including a small and
deformed rib cage and a shorter skull (Fig. 2D). The later
phenotype suggested differences in bone formation. Indeed,
histological sections of femurs demonstrated that KD animals
displayed thinner cortical bone right after birth and in particular
at postnatal day 14 (Fig. 2E).
To examine ossification patterns in Rac1 KD animals,
histological analyses were performed by safranin O/Fast green
staining. At embryonic day 16.5 (E16.5), control femurs
displayed an osseous center, whereas the center of Rac1-
deficient bones was still comprised of hypertrophic cartilage
(Fig. 3A). Similarly, secondary ossification was well advanced
in the femur and humerus of postnatal day 14 (P14) control mice,
but greatly delayed in mutant mice (Fig. 3B). Primary
ossification was also delayed in E16.5 Rac1 KD tibia (Fig.
3C). Immunohistochemistry demonstrated that collagen X
expression is already separated into two domains, separated by
amineralized core, in control mice, whereas mutant mice display
one continuous zone of collagen X expression (Fig. 3D).
Overall, the area of collagen X expression is slightly smaller in
KD mice, suggesting a subtle delay in chondrocyte differentia-
tion. In contrast, vascular invasion is greatly delayed in mutant
Fig. 1. Loss of Rac1 in cartilage results in reduced viability and growth.Western blotting for Rac1 protein was performed in cartilage, brain, kidney and lung extracts of
Col2Cre-Rac1fl/fl mice (KD) and Rac1fl/fl littermates without the Cre transgene (Con) (A). Cartilage from Col2Cre-Rac1fl/fl mice showed a strong reduction in Rac1
protein levels, while Rac1 levels in all other tissues do not differ between KD and Con mice. Equal protein loading was documented by blotting for β-actin.
Immunohistochemistry on newborn tibia sections demonstrated reduced Rac1 protein levels in the resting zone (RZ) of mutant mice (KD) compared to controls (Con),
with even greater reduction in cells of the proliferating (PZ) and hypertrophic (HZ) zones (B; scale bar=25 μm). Genotyping of living pups in the first 2 weeks of life
showed that 13% of viable offspring had the Col2Cre-Rac1fl/fl genotype (C). Surviving Col2Cre-Rac1fl/fl newborn pups were smaller than control littermates (D).
Body length (E) and weight (F) of Col2Cre-Rac1fl/fl (KD) and control (Con) mice were determined throughout the first 6 weeks of life. KD mice were shorter and
lighter at birth, and differences between genotypes increased as mice aged. Average and standard deviation from 10 mice per genotype are shown for each data point
(*: p<0.05).
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PECAM (Fig. 3E). These data demonstrate a severe delay in
primary and secondary ossification in Rac1 KD mice.
Rac1 deficiency results in disorganized growth plates and
reduced chondrocyte proliferation
To elucidate the cellular basis for the skeletal phenotype, we
analyzed growth plate organization at different developmental
stages. Growth plates from knockout animals were severely
disorganized and displayed a marked reduction in columnar
structures (Fig. 4A). Furthermore, loss of Rac1 expression
resulted in altered cell shape of chondrocytes, in particular in the
proliferative zone where cells are normally flattened, but
appeared more rounded in KD animals. Cells in mutants also
displayed much greater diversity in cell shape and size, as well as
intermixing of small and very large cells in the hypertrophic zone
(Fig. 4A, magnifications). In addition, Rac1-deficient growth
plates were hypocellular, especially in the center of the growthplate. Measurement of the length of different growth plate zones
revealed that both the proliferative and the hypertrophic zone are
shortened in KD mice (Fig. 4B). Analyses of additional long
bones and developmental stages confirmed that growth plate
disorganization and hypocellularity are general features of Rac1-
deficient growth plates (Fig. 4C). Furthermore, while the
number of hypertrophic chondrocytes was reduced in KD
cartilage, many of these cells were very large.
Rac1-deficient chondrocytes show reduced spreading and
adhesion
The severe disorganization of Rac1-deficient growth plates
suggested that cell–ECM interactions are altered in Rac1mutant
mice. To investigate this possibility, primary Rac1-deficient and
control chondrocytes were plated on collagen II- or fibronectin-
coated coverslips for 30 min and counted (Fig. 5A). Loss of
Rac1 resulted in a 52% and 60% reduction in the number of cells
adhering to fibronectin and collagen II, respectively. We also
Fig. 2. Rac1-deficiency results in reduced skeletal growth and delayed ossification. Whole skeletons of newborn mice were stained with alcian blue and alizarin red,
revealing severe kyphosis in KD animals (A). Enlargement of the axial skeleton from panel A confirms curvature in mutants, but no other morphological changes (B).
T12, T13 and L1 vertebra showed no morphological differences between genotypes besides reduced size in mutants. Measurement of tibia and femur length in newborn
mice demonstrated reduced length of KD bones (C; average and standard deviation from 10 bones each are shown). Selected bones were stained in 3-week old mice,
confirming reduced bone size in these animals (D). Paraffin sections of newborn (p0) and 2-week old (p14) femurs demonstrate thinner cortical bone in mutant mice (E).
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after plating, control cells plated on fibronectin were well spread
and displayed cortical organization of actin fibers, vinculin and
focal adhesion kinase (FAK) phosphorylated on tyrosine 397, in
addition to cytosolic staining for these parameters (Fig. 5B). In
contrast, Rac1-null chondrocytes, while adherent at this time
point, had spread much less and displayed only diffuse staining
for polymerized actin, vinculin and phosphorylated FAK, with
no apparent cortical staining. Similar results were obtained with
cells plated on collagen II (data not shown). These data suggest
that Rac1 is required for normal interactions of chondrocytes
with the ECM and for cell spreading.
Rac1 is required for chondrocyte proliferation and survival
Since Rac1-deficient growth plates appeared hypocellular
(Figs. 6A, B), we examined proliferation and apoptosis. Cell
counts demonstrated a 40% reduction in total cell numbers (per
area) in the proliferative zone of KD growth plates (Fig. 6C).
BrdU incorporation assays showed a dramatic reduction in
replicating cells in KD growth plates (Fig. 6B) that was
confirmed by counts of positively labeled cells (relative to totalcell number) (Fig. 6D). Similarly, numbers of cyclin D1-positive
cells (relative to total cell number) were reduced in KD cartilage
(Fig. 6E). These data suggest reduced cyclin D1 expression
resulting in slower cell cycle progression and decreased
proliferation upon loss of Rac1. However, immunohistochem-
istry demonstrated that expression of p57, a cell cycle inhibitor
required for normal hypertrophic differentiation, is also reduced
in KD cells (Fig. 6F). We next performed TUNEL staining in
mutant cartilage to examine apoptosis (Fig. 6G). In control mice,
TUNEL staining was restricted to terminal hypertrophic cells at
the cartilage–bone junction. In contrast, mutant mice demon-
strated more apoptotic cells and an earlier onset of apoptosis.
Counting of TUNEL positive cells showed a three-fold increase
in Rac1 KD growth plates (data not shown).
Rac1 controls p38 activity and cartilage-specific gene
expression
We and others had demonstrated important roles of p38
MAP kinase activity in cartilage development in vitro and in
vivo (Stanton et al., 2003, 2004; Zhang et al., 2006; Zhen et al.,
2001), and our recent studies suggest that p38 signaling
Fig. 3. Rac1-deficiency results in reduced skeletal growth and delayed ossification. Sections of embryonic day 16.5 (E16.5) femurs were analyzed by safranin O/Fast
green staining and demonstrate the presence of an ossified center (OC) in control bones, whereas the center of the bone was comprised of hypertrophic cartilage (H) in
KD animals (A). Sections of postnatal day 14 (P14) femurs and humeri were compared by safranin O/Fast green staining. Secondary ossification was advanced in
control mice, but greatly delayed in KD animals (B). Mineralization and cartilage resorption are also delayed in mutant E16.5 femurs (C). Immunohistochemistry for
collagen X confirms the absence of an osseous center in mutant E16.5 tibia (D), and PECAM staining demonstrates delayed vascular invasion into KD E16.5 tibiae (E).
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Therefore we examined the activation status of p38 in our mice.
Parallel studies were performed for Akt proteins, another family
of kinases that has been implicated in Rac1 signaling (Fukuda et
al., 2005; Gonzalez et al., 2006; Sun et al., 2004). Total p38 and
Akt proteins were immunoprecipitated directly from cartilage
lysate and analyzed by western blotting with antibodies against
total or phosphorylated p38 and Akt proteins. p38 phosphor-
ylation was greatly reduced in Rac1-null cartilage (Fig. 7A). In
contrast, the phosphorylation of Akt kinases was only margin-
ally lower in mutant cartilage.
We had shown that p38 activity is required for the expression
of the late chondrocyte markers collagen X and bone
sialoprotein (BSP) (Stanton et al., 2004), but both our in vitro
experiments (Stanton and Beier, 2007) and a recent in vivo
study (Zhang et al., 2006) have demonstrated repression of
IHH, an important regulator of skeletal development, by p38
signaling. We analyzed the expression of these p38 target genes
by real-time PCR using RNA directly extracted from cartilage
and by immunohistochemistry. mRNA expression of all three
genes was significantly increased in KD cartilage (Fig. 7B).
Immunohistochemistry confirmed more intensive collagen Ximmunostaining staining as well as an expanded domain of
staining upon Rac1 inactivation, with staining initiating in the
transition from proliferative to hypertrophic zone (Fig. 7C),
suggesting that the coordination between cell cycle exit, cellular
hypertrophy and differentiation-specific gene expression is lost
upon inactivation of the Rac1 gene.
Similarly, expression of the Indian hedgehog (IHH) gene
(Ihh) was increased in mutant cartilage (Fig. 7B). Immunohis-
tochemistry also showed increased expression of the IHH
receptor patched in KD growth plates, in particular at the
transition from proliferating to hypertrophic chondrocytes (Fig.
7D). Since patched expression is stimulated by hedgehog
proteins, increased patched staining upon loss of Rac1 provides
further evidence that IHH signaling is elevated in Rac1-
deficient cartilage.
Discussion
The intracellular signaling pathways that control growth
plate chondrocyte proliferation and differentiation are incom-
pletely understood. Here we provide evidence for an essential
role of the small GTPase Rac1 in this context. Our data show
Fig. 4. Rac1 deficiency causes altered growth plate organization and chondrocyte cell shape. Growth plate organization in Col2Cre-Rac1fl/fl (KD) and control (Con)
mice was investigated by hematoxylin/eosin staining of femurs from newborn mice (P0) (A; scale bar=200 μm). KD growth plates demonstrated disorganized growth
plates with loss of columnar organization and irregular cell shape in chondrocytes from the proliferative and hypertrophic zones (see enlarged boxes in panel A). KD
growth plates also showed hypocellularity. Morphometric measurements revealed shorter proliferative and hypertrophic zones in mutant animals (B; averages and
standard deviation from ten different sections are shown; *: p<0.05). Safranin O/Fast green staining of E18.5 humeri, P0 tibiae and P5 femurs confirmed growth plate
disorganization and hypocellularity in additional bones and developmental stages (C; scale bar=200 μm).
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in marked reduction of endochondral bone growth. Analyses at
the tissue, cellular and molecular level suggest that these effects
are likely due to modulation of several pathways with known
roles in cartilage differentiation, including integrin signaling
and the p38 pathways.
Cartilage-specific deletion of the Rac1 gene resulted in
approximately 50% of the expected number of offspring,
suggesting that this mutation reduces viability. Our observa-
tions suggested that respiratory distress, possible due to a
deformed rib cage, is one reason for the increased lethality,
similar to other mouse mutants with severe defects in
endochondral ossification (Karaplis et al., 1994; Schipani et
al., 2001). Skeletal staining confirmed that loss of Rac1
results in multiple defects in endochondral ossification,
including reduced size and malformations such as kyphosis.
Many of these phenotypes appear to be secondary to growth
plate defects. Loss of Rac1 leads to a disorganized growth
plate and almost complete loss of columnar organization, in
addition to abnormal cell shape and size, reduced proliferation
and decreased cyclin D1 expression. These phenotypes are
highly reminiscent of mice with cartilage-specific deletion ofthe β1 integrin (Aszodi et al., 2003) or integrin-linked kinase
(ILK) (Grashoff et al., 2003; Terpstra et al., 2003) genes.
These data, together with established roles of Rac1 in integrin
signaling (Arthur et al., 2002; DeMali et al., 2003; Juliano,
2002; Juliano et al., 2004), suggest that altered cell–ECM
interactions contribute to the phenotype observed in our KD
mice. Furthermore, a recent study suggested that β1 integrin
signaling can induce phosphorylation of Rac1 in chondrocytes
in vitro (Johnson and Terkeltaub, 2005). Our cell adhesion
assays demonstrate reduced adhesion of Rac1-deficient
chondrocytes to collagen II and fibronectin. These in vitro
studies also show deficiencies in the organization of the actin
cytoskeleton and the cellular localization of vinculin and
phosphorylated FAK in the absence of Rac1. Taken together,
our data suggest that interruption of signaling from the ECM
to the actin cytoskeleton and other cellular effectors (such as
the cell cycle machinery) contributes greatly to the severe
skeletal phenotype observed upon cartilage-specific inactiva-
tion of the Rac1 gene. These data also suggest that β1
integrin, Rac1 and ILK act in a common pathway regulating
cartilage development, but the exact connections between
these three genes remain to be resolved.
Fig. 5. Rac1-deficient chondrocytes display reduced adhesion and spreading. Primary control (Con) and Rac1-deficient (KD) chondrocytes were plated onto
fibronectin- or collagen II-coated wells. After 30 min, wells were washed, and cells were trypsinized and counted (A). Data shown represent average and standard
deviation from three independent trials (*: p<0.05). Twenty-four hours after plating, wells were stained with DAPI (blue) for nuclei, with rhodamine phalloidin (red)
for actin filaments and with antibodies (green) against vinculin or FAK phosphorylated on Y397 (B; scale bar=10 μm). Cells plated on fibronectin are shown in panel
B, but plating on collagen II resulted in similar patterns. Rac1 deficiency resulted in reduced cell adhesion and spreading and a loss of cortical localization of actin
filaments, vinculin and phosphorylated FAK.
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appears to be partially due to a decline in cyclin D1 expression,
resulting in reduced proliferation and slower cell cycle
progression. It is noteworthy that this happens despite increasedexpression and activity of IHH, a protein known to stimulate
chondrocyte proliferation and cyclin D1 production (Long et al.,
2001). It is likely that other effects of Rac1 deficiency override
the effects of increased IHH signaling, in agreement with the
Fig. 6. Rac1 deficiency results in decreased proliferation and increased apoptosis. Safranin O/Fast green stain of tibia sections from newborn mutant (KD) and control
(Con) showed hypocellularity in KD growth plates (A) that was confirmed by cell counts (C). BrdU labelling followed by immunohistochemistry with a BrdU-specific
antibody showed greatly reduced numbers of labelled cells in KD growth plates (B; scale bar=200 μm) which was confirmed by counting of labelled cells (D). A
similar reduction was seen when counting cells stained with an antibody against cyclin D1 (E). All cell counts present average and standard deviation from 3 counts
from each of three different mice per genotype (*: p<0.05). Immunohistochemistry demonstrated reduced expression of p57 in mutant growth plates (F), whereas
TUNEL staining revealed increased apoptosis upon loss of Rac1 (G).
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multiple signaling pathways in chondrocytes (Beier, 2005).
Since we also observed increased and premature apoptosis in
mutant cartilage, the observed hypocellularity of Rac1-deficient
growth plates is likely caused by a combination of reduced
proliferation and increased cell death.
At the molecular level, Rac1 deficiency causes reduced
activity of the p38 kinase pathway and altered expression of
Ihh. A recent study showed that activation of p38 signaling in
chondrocytes in vivo leads to reduced Ihh expression (Zhang et
al., 2006). In agreement with these data, we have shown that
pharmacological inhibition of p38 in chondrocyte monolayer or
micromass culture results in increased Ihh transcript levels
(Stanton and Beier, 2007). It is therefore plausible to speculate
that reduced p38 activity in Rac1-deficient chondrocytescontributes to increased Ihh levels in chondrocytes. It will be
of great interest to decipher whether alteration in p38 activity
also contributes to other outcomes of Rac1 deficiency, such as
altered cell–ECM interactions. Alternatively, these processes
might mediate the activation of p38 by Rac1 signaling.
However, it should be noted that expression of the hypertrophic
markers collagen X and BSP was elevated in mutant cells,
despite reduced p38 activity. These data suggest that additional
downstream pathways affected by Rac1 deficiency override the
effects of reduced p38 activity on hypertrophic gene expression.
Similarly, we show increased expression and activity of IHH,
but the phenotype of our mice does not correspond to expected
effects of increased IHH signaling. For example, IHH is known
to promote both chondrocyte proliferation and periosteal bone
formation (Ehlen et al., 2006), but we observe the opposite
Fig. 7. Reduced p38 activity and increased collagen X and Indian hedgehog expression in Rac1-deficient cartilage. Total p38 and Akt proteins were
immunoprecipitated from RIPA extracts of newborn cartilage and analyzed by western blotting for p38, phosphorylated p38 (p-p38), Akt and phosphorylated Akt (p-
Akt) (A). p38 phosphorylation was greatly and Akt phosphorylation was slightly reduced in Rac1-deficient cartilage. Representative blots from three independent
experiments are shown. RNAwas isolated directly from the cartilage of long bones from newborn Col2Cre-Rac1fl/fl mice (KD) and control littermates (Con). Real-
time PCR revealed increased expression of collagen X, bone sialoprotein (BSP) and Ihh mRNAs in KD cartilage, relative to levels in control mice (set at a value of 1
for each gene) (B). Real-time PCR data represent average and SEM from three independent experiments (*: p<0.05). Immunohistochemistry on newborn tibia
sections confirmed a wider zone of collagen X expression (C) and more chondrocytes expressing the IHH receptor and target patched (D) in Rac1 KD mice (scale
bar=200 μm).
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tion for this discrepancy is that increased expression of Ihh,
which is only expressed in postmitotic chondrocytes, is simply
due to the reduced proliferation and earlier differentiation of
Rac1-deficient chondrocytes. Increased levels of IHH might
therefore not contribute to the phenotype of Rac1 KD mice, but
in contrast counteract these effects. However, the relatively
modest upregulation of Ihh might not be sufficient to overcome
the severe effects of loss of Rac1. Subsequent studies will need
to address these possibilities.
We had shown earlier that overexpression of Rac1 in the
chondrogenic cell line ATDC5 accelerates progression through
the chondrocyte life cycle, e.g. inducing earlier withdrawal from
the cell cycle, earlier hypertrophic differentiation and earlier
apoptosis (Wang and Beier, 2005). These effects are consistent
with the phenotype of our loss-of-function model that is
characterized by delayed skeletal development (e.g. delay in
primary and secondary ossification). In addition, increased p38
activity in our gain-of-function cell model is matched by
reduced p38 phosphorylation in the knockout model. In
addition, our data suggest that hypertrophic differentiation is
slightly delayed in mutant mice at E16.5, as predicted from our
in vitro studies. However, at later stages we observed
accelerated onset of hypertrophy as demonstrate by increased
and earlier expression of collagen X and other maturation
markers. This points towards stage-specific effects of Rac1
deficiency. At early stages, Rac1 appears to be required for
normal hypertrophic differentiation, but overall growth platearchitecture is not affected markedly by loss of Rac1. Later in
development, effects of Rac1 on growth plate architecture and
chondrocyte proliferation seem to become dominant, leading to
earlier cell cycle exit and onset of hypertrophic differentiation.
Moreover, our in vitro studies also predicted increased
proliferation and reduced apoptosis in Rac1-deficient growth
plates, the opposite phenotypes of what we actually observed.
There are several potential explanations for this discrepancy. It
is possible that both increased activity (in ATDC5 cells) and
reduced activity (in mutant mice) cause similar cellular
outcomes. Another, more likely possibility is that certain
aspects of Rac1 in vivo function – e.g. the maintenance of three-
dimensional growth plate organization and tightly controlled
cell–ECM interactions – cannot be recapitulated in a standard
two-dimensional cell culture system.
Although inactivation of the Rac1 gene was driven by the
cartilage-specific collagen II promoter, we observed profound
changes in the skull skeleton and cortical bone. In mutant mice,
the skull was shorter and appeared less mineralized; in addition,
cortical bone was thinner. This could be partially explained by
altered cartilage development. For example, several bones of
the skull (including the cranial base) develop through
endochondral ossification, and improper development of these
bones could result in an overall altered skeletal structure of the
skull. In particular, the length of the skull is mostly controlled
by endochondral ossification and appears to be more affect than
the width of the skull. Similarly, signals from chondrocytes
regulate perichondral/periosteoal bone formation, and altera-
622 G. Wang et al. / Developmental Biology 306 (2007) 612–623tions in these signals could affect cortical bone mass. However,
an alternative (although not exclusive) explanation is that
transient expression of Cre in osteoblast precursors or
perichondral cells in our mice results in partial Rac1 deficiency
in these cells, thus directly contributing to the observed bone
phenotypes. Experiments to address these possibilities are under
way in our laboratory.
In summary, our data clearly demonstrate a requirement for
Rac1 in endochondral bone development. Loss of Rac1
function in chondrocytes affects numerous aspects of growth
plate physiology, including gene expression, cell–ECM inter-
actions and p38 activity. It appears likely that the overall
phenotype of Rac1-deficient cartilage is a combination of
alterations in all these processes. In addition, this study
identifies phenotypes that could not have been predicted a
priori, e.g. by studies in other tissues or cell types. Our results
therefore demonstrate that even a gene like Rac1, which is
ubiquitously expressed and appears to perform similar bio-
chemical functions in many, if not all cell types (e.g. the control
of actin dynamics and cellular morphology), has tissue-specific
functions that need to be studied in the appropriate physiolo-
gical context. Elucidation of the role of the various downstream
effectors in the skeletal phenotype induced by loss of Rac1 and
the molecular connections between them will be crucial for a
better understanding of normal and pathological endochondral
bone formation.
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